Home
About
Overview
Sharing Data
ORCID
Help
History (5)
A FluoPol-ABPP PAD2 high-throughput screen identifies the first calcium site inhibitor targeting the PADs.
Human sebaceous tumors harbor inactivating mutations in LEF1.
Micrococcal-Nuclease-Triggered On-Demand Release of Vancomycin from Intramedullary Implant Coating Eradicates Staphylococcus aureus Infection in Mouse Femoral Canals.
Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial.
Protein arginine deiminase 4: evidence for a reverse protonation mechanism.
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Protein arginine deiminase 4: evidence for a reverse protonation mechanism.
Knuckley B, Bhatia M, Thompson PR. Protein arginine deiminase 4: evidence for a reverse protonation mechanism. Biochemistry. 2007 Jun 05; 46(22):6578-87.
View in:
PubMed
subject areas
Amino Acid Sequence
Arginine
Binding Sites
Citrulline
Cysteine
Histidine
Humans
Hydrogen-Ion Concentration
Hydrolases
Kinetics
Molecular Sequence Data
Mutagenesis, Site-Directed
Protein Processing, Post-Translational
Protein-Arginine Deiminases
Protons
Recombinant Proteins
Substrate Specificity
authors with profiles
Paul R Thompson PhD